De Lusheng
2010-04-13 14:57:38 ԴҵľWվ g[7033    

 

De Lusheng Recombinant Human Interleukin-2 for Injection

 

RhIL-2 is produced by gene recombination technique. Compared with nature product, its biologic activity in vivo is in accordant with that in vitro. IL-2 is a kind of lymph gene that activated by the lymph cells, which can stimulate the killer T lymph cells (CTL), natural killing cells (NK) or the macrophage increase and killing functions of cells. It can also induce other lymph gene such as - the secretion of the interferon and lymph toxicity, which can induce and engender the killing cells that activated by the lymph gene (LAK), the latter one can dissolve the tumor cells directly. Solely using IL-2 or the IL-2 plus LAK enables to eliminate the tumors of the animals. In 1985, Rosenberg and others reported that using IL-2 plus LAK enables to obtain the clinical remission for partly patients with terminal melanoma and kidney cancer.

 

 

 

 
    ַf_l^5̖ ]100176
Ԓ0086-10 51570800, 51570870, 51570818, 51570855
棺0086-10 51410080, 51570860
Wַwww.bjshsw.com www.qjdt.net
ǰλã >> english >> x

F0ˌİluՓ 鿴uՓ


jbo <֩>| <֩>| <֩>| <֩>| <֩>| <֩>| <֩>| <֩>| <֩>| <֩>| <֩>| <֩>| <֩>| <֩>| <֩>| <֩>| <֩>| <֩>| <֩>| <֩>| <֩>| <֩>| <֩>| <֩>| <֩>| <֩>| <֩>| <֩>| <֩>| <֩>| <֩>| <֩>| <֩>| <֩>| <֩>| <֩>| <֩>| <֩>| <֩>| <֩>| <֩>| <ı> <ı> <ı> <ı> <ı> <ı>